MR perfusion in and around the contrast-enhancement of primary CNS lymphomas

Journal of Neuro-Oncology

Volumn 114, Issue 1, 2013, Pages 127-134

  Blasel, Stella ^a   Jurcoane, Alina ^a   Bähr, Oliver ^a   Weise, Lutz ^a   Harter, Patrick N ^b   Hattingen, Elke ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Glioblastoma; MR perfusion; Primary CNS lymphoma; rCBV; Tumor infiltration

Indexed keywords

GADOBUTROL; RETICULIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BRAIN BLOOD VOLUME; BRAIN PERFUSION; CANCER INFILTRATION; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; ONCOLOGICAL PARAMETERS; PENUMBRA; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; RADIODIAGNOSIS; RADIOLOGICAL PARAMETERS; REGIONAL BRAIN BLOOD VOLUME; RETICULIN FIBER NETWORK; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SUSCEPTIBILITY WEIGHTED IMAGING; TIME SIGNAL INTENSITY CURVE; TUMOR INVASION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; BLOOD VESSELS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; CONTRAST MEDIA; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LYMPHOMA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; RETROSPECTIVE STUDIES;

EID: 84881149496     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1161-z     Document Type: Article

References (49)

1. Aho R, Ekfors T, Haltia M, Kalimo H (1993) Pathogenesis of primary central nervous system lymphoma: invasion of malignant lymphoid cells into and within the brain parenchyme. Acta Neuropathol 86:71-76
2. Coulon A, Lafitte F, Hoang-Xuan K, Martin-Duverneuil N, Mokhtari K, Blustajn J, Chiras J (2002) Radiographic findings in 37 cases of primary CNS lymphoma in immunocompetent patients. Eur Radiol 12:329-340
3. Gliemroth J, Kehler U, Gaebel C, Arnold H, Missler U (2003) Neuroradiological findings in primary cerebral lymphomas of non-AIDS patients. Clin Neurol Neurosurg 105:78-86
4. Go JL, Lee SC, Kim PE (2006) Imaging of primary central nervous system lymphoma. Neurosurg Focus 21:E4
5. Valles FE, Perez-Valles CL, Regalado S, Barajas RF, Rubenstein JL, Cha S (2013) Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma. AJNR Am J Neuroradiol 30:35-40
6. Lai R, Rosenblum MK, DeAngelis LM (2002) Primary CNS lymphoma: a whole-brain disease? Neurology 59:1557-1562
7. Stadnik TW, Chaskis C, Michotte A, Shabana WM, van Rompaey K, Luypaert R, Budinsky L, Jellus V, Osteaux M (2001) Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 22:969-976
8. Blasel S, Franz K, Ackermann H, Weidauer S, Zanella F, Hattingen E (2011) Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery. J Neurooncol 103:575-584
9. Blasel S, Jurcoane A, Franz K, Morawe G, Pellikan S, Hattingen E (2010) Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas. Acta Neurochir (Wien) 152:1893-1899
10. Chiang IC, Kuo YT, Lu CY, Yeung KW, Lin WC, Sheu FO, Liu GC (2004) Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 46:619-627
11. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715-721
12. Jiddane M, Nicoli F, Diaz P, Bergvall U, Vincentelli F, Hassoun J, Salamon G (1986) Intracranial malignant lymphoma. Report of 30 cases and review of the literature. J Neurosurg 65:592-599
13. Scatliff JH, Guinto FC Jr, Radcliffe WB (1971) Vascular patterns in cerebral neoplasms and their differential diagnosis. Semin Roentgenol 6:59-69
14. Scatliff JH, Radcliffe WB, Pittman HH, Park CH (1969) Vascular structure of glioblastomas. Am J Roentgenol Radium Ther Nucl Med 105:795-805
15. D'Haene N, Catteau X, Maris C, Martin B, Salmon I, Decaestecker C (2008) Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas. Br J Haematol 140:402-410
16. Sugita Y, Takase Y, Mori D, Tokunaga O, Nakashima A, Shigemori M (2007) Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival. J Neurooncol 82:249-256
17. Takeuchi H, Matsuda K, Kitai R, Sato K, Kubota T (2007) Angiogenesis in primary central nervous system lymphoma (PCNSL). J Neurooncol 84:141-145
18. Roser F, Saini M, Meliss R, Ostertag H, Samii M, Bellinzona M (2004) Apoptosis, vascularity, and proliferation in primary central nervous system lymphomas (PCNSL): a histopathological study. Surg Neurol 62:393-399
19. Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M (2006) Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 24:817-824
20. Lee IH, Kim ST, Kim HJ, Kim KH, Jeon P, Byun HS (2010) Analysis of perfusion weighted image of CNS lymphoma. Eur J Radiol 76:48-51
21. Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T (2006) Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 58:394-403
22. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 223:11-29
23. Hartmann M, Heiland S, Harting I, Tronnier VM, Sommer C, Ludwig R, Sartor K (2003) Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 338:119-122
24. Liao W, Liu Y, Wang X, Jiang X, Tang B, Fang J, Chen C, Hu Z (2009) Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 50:217-225
25. Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F (2006) Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 48:150-159
26. Sugahara T, Korogi Y, Shigematsu Y, Hirai T, Ikushima I, Liang L, Ushio Y, Takahashi M (1999) Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 23:232-237
27. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109
28. Rorden C, Brett M (2000) Stereotaxic display of brain lesions. Behav Neurol 12:191-200
29. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM (2012) FSL. Neuroimage 62:782-790
30. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 36:715-725
31. Rosen BR, Belliveau JW, Vevea JM, Brady TJ (1990) Perfusion imaging with NMR contrast agents. Magn Reson Med 14:249-265
32. Schlegel U, Schmidt-Wolf IG, Deckert M (2000) Primary CNS lymphoma: clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 181:1-12
33. Molnar PP, O'Neill BP, Scheithauer BW, Groothuis DR (1999) The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death. Neuro Oncol 1:89-100
34. Watanabe M, Tanaka R, Takeda N, Wakabayashi K, Takahashi H (1992) Correlation of computed tomography with the histopathology of primary malignant lymphoma of the brain. Neuroradiology 34:36-42
35. Rubenstein JL, Fridlyand J, Shen A, Aldape K, Ginzinger D, Batchelor T, Treseler P, Berger M, McDermott M, Prados M, Karch J, Okada C, Hyun W, Parikh S, Haqq C, Shuman M (2006) Gene expression and angiotropism in primary CNS lymphoma. Blood 107:3716-3723
36. Kleihues P, Burger BC, Scheithauer BW (1999) Histological typing of tumours of the central nervous system. Springer Verlag, Berlin
37. Salven P, Teerenhovi L, Joensuu H (1997) A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood 90:3167-3172
38. Kim IY, Jung S, Jung TY, Kang SS, Choi C (2008) Primary central nervous system lymphoma presenting as an acute massive intracerebral hemorrhage: case report with immunohistochemical study. Surg Neurol 70:308-311
39. Rubenstein J, Fischbein N, Aldape K, Burton E, Shuman M (2002) Hemorrhage and VEGF expression in a case of primary CNS lymphoma. J Neurooncol 58:53-56
40. Wang ES, Teruya-Feldstein J, Wu Y, Zhu Z, Hicklin DJ, Moore MA (2004) Targeting autocrine and paracrine VEGF receptor pathways inhibits human lymphoma xenografts in vivo. Blood 104:2893-2902
41. Claes A, Idema AJ, Wesseling P (2007) Diffuse glioma growth: a guerilla war. Acta Neuropathol 114:443-458
42. Plate KH, Breier G, Weich HA, Mennel HD, Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int J Cancer 59:520-529
43. Plate KH, Scholz A, Dumont DJ (2012) Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited. Acta Neuropathol 124:763-775
44. Wesseling P, Van der Laak JA, de Leeuw H, Ruiter DJ, Burger PC (1994) Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. Computer-assisted image analysis of whole-tumor sections. J Neurosurg 81:902-909
45. Mangla R, Kolar B, Zhu T, Zhong J, Almast J, Ekholm S (2011) Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 32:1004-1010
46. Berghoff AS, Spanberger T, Ilhan-Mutlu A, Magerle M, Hutterer M, Woehrer A, Hackl M, Widhalm G, Dieckmann K, Marosi C, Birner P, Prayer D, Preusser M (2013) Preoperative diffusion-weighted imaging of single brain metastases correlates with patient survival times. PloS One 8:e55464
47. Heiland S, Benner T, Debus J, Rempp K, Reith W, Sartor K (1999) Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. Magn Reson Imaging 17:21-27
48. Heiland S, Hartmann M, Sartor K (2000) Is perfusion MRI feasible in lesions with disrupted blood-brain barrier? Pitfalls and possible solutions. Rofo 172:812-816
49. Uematsu H, Maeda M (2006) Double-echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability. Eur Radiol 16:180-186